TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS
Re:Opposition by Matthias Rath to registration of trade mark application 902498(5) - DIASTOR - filed in the name of Biofarma.
Delegate: Deirdre O'Brien Representation: Opponent
Written submissions by Ms Natalie Murray-Jones of Griffith Hack
Applicant
Mr Wayne Willis of F B Rice & CoDecision: S44 ground not made out. Trade mark may be registered. Background
Trade mark application no 902498 in the name of Biofarma (‘the applicant’) is an International Registration Designating Australia. It was accepted for registration by this office but registration has been opposed by Matthias Rath (‘the opponent’). Upon being advised of the opposition, the applicant nominated F B Rice & Co as its address for service. The opponent is represented by the attorney firm Griffith Hack.
The opponent filed and served evidence in support[1]. The applicant responded by filing and serving evidence in answer[2]. The matter was set down for hearing by me in Sydney on 21 July 2004. Mr Wayne Willis of F B Rice & Co appeared for the applicant. Ms Natalie Murray-Jones of Griffith Hack made written submissions on behalf of the opponent.
[1] Statutory declaration by the opponent Matthias Rath, made 31 October 2003.
[2] Statutory declaration by Scott McKinnon of F B Rice & Co, made 22 January 2004.
Ground of opposition
Ms Murray-Jones’s submissions all go to the ground of opposition under section 44 of the Trade Marks Act 1995. She cites the opponent’s registration no 860021 in support. Relevant details of that registration and of this application are as follows:
This application Cited registration Trade Mark diastor diacor Priority date 23 July 2001 11 December 2000 Class 5 goods Pharmaceutical products Pharmaceutical preparations; vitamins and minerals for medical purposes; food supplements for non-medical purposes including those consisting of vitamins, amino acids, minerals and trace elements, dietetic substances for non-medical purposes, including amino acids and trace elements; all of the following for human use
Two legs of the section 44 ground are already established. The goods covered by each trade mark are the same and the cited trade mark has an earlier priority date. Ms Murray-Jones’s arguments go to the third leg, namely whether the trade marks are deceptively similar. She says that, although there are 77 trade marks on the register which have the prefix dia- and which are for class 5 goods, only two others share the prefix dia- and the suffix –or. Those trade marks are diadabor and diaplexor. According to Ms Murray-Jones the differences in the middle syllables of those trade marks means they can be distinguished both visually and phonetically. Here the subject trade mark diastor and the cited trade mark diacor have only minor differences in their middle parts and, applying the standard tests[3], Ms Murray-Jones argues they are both visually and aurally deceptively similar.
[3] Shell Co (Aust) Ltd v Esso Standard Oil (Aust) Ltd (1964) 109 CLR 407; Pianotist Co’s Appn (1906) 23 RPC…
Keep reading for free
Create a free CaseChat account to read Matthias Rath v Biofarma and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2004] ATMO 55
- Decision Date
CaseChat Overview and Summary
The primary legal issue before the Senior Examiner was whether Biofarma had established that the applicant's trade mark was deceptively similar to any of its registered trade marks, such that it would be likely to deceive or cause confusion in the marketplace. This required an assessment of the "third leg" of section 44, which pertains to the likelihood of deception or confusion.
The Senior Examiner found that Biofarma had failed to provide any evidence of actual deception or confusion in the Australian marketplace. While Biofarma had provided sales figures for its trade mark use in Europe, there were no Australian sales figures despite the trade mark's first use in Australia dating back to August 2002. The applicant had also not provided evidence of use. Consequently, the Senior Examiner concluded that the ground of opposition under section 44 had not been made out, finding that the trade marks were not deceptively similar.
Trade mark application number 902498 was permitted to proceed to registration one month from the date of the decision, unless a notice of appeal was filed with the Registrar, in which case registration would be stayed pending the outcome of the appeal. Costs were awarded against Biofarma according to the Official Scale.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.